Magdalena Kunat-Budzyńska

Mrs. Magdalena Kunat-Budzyńska

Maria Curie-Skłodowska University, Lublin, Lubelskie, Poland

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 October 2022 in Pathogens
Verified
Journal Article
Open access
PDF file
MKMagdalena Kunat-Budzyńska
Magdalena Kunat-Budzyńska
MBMichał Budzyński
Michał Budzyński
MSMichał Schulz
Michał Schulz
Aneta StracheckaAneta Strachecka
Aneta Strachecka
Marek GancarzMarek Gancarz
Marek Gancarz
Aneta A. PtaszyńskaAneta A. Ptaszyńska
Aneta A. Ptaszyńska
Honeybees are important pollinators, but they are continuously exposed to a variety of fungal and bacterial diseases. One of the various diseases affecting honeybees is nosemosis caused by microsporidia from the Nosema genus. Honeybees are mainly infected through consumption of infected food or faeces containing Nosema spp. spores. Nosemosis causes damage to the middle intestine epithelium, which leads to food absorption disorders and honeybee malnutrition. Fumagillin, i.e., the antibiotic used to treat nosemosis, was withdrawn in 2016 from EU countries. Therefore, researchers have been looking for compounds of both natural and synthetic origin to fight nosemosis. Such compounds should not have a negative impact on bees but is expected to inhibit the disease. Natural compounds tested against nosemosis include, e.g., essential oils (EOs), plant extracts, propolis, and bacterial metabolites, while synthetic substances tested as anti-nosemosis agents are represented by porphyrins, vitamins, antibiotics, phenolic, ascorbic acids, and others. This publication presents an 18-year overview of various studies of a number of natural and synthetic compounds used in the treatment and prevention of nosemosis cited in PubMed, GoogleScholar, and CrossRef.